[1]
|
陶涛,刘璠娜,尹良红.终末期糖尿病肾病治疗的研究进展[J].广东医学,2012,32(24):3289. |
[2]
|
DURAN-SALGADO MB,RUBIO-GUERRA AF. Diabetic nephropathy and inflammation[J].World J Diabetes,2014,5(3):393. |
[3]
|
杨玉玺.甘露聚糖结合凝集素途径的补体激活与肾脏疾病的关系[J].国际泌尿系统杂志,2010,30(2):241. |
[4]
|
颜晓勇,黄颂敏,吴蔚桦,等.甘露聚糖结合凝集素-A在早期糖尿病大鼠肾脏中的表达及意义[J].广东医学,2011,32(12):1515. |
[5]
|
KILPATRICK DC. Mannan-binding lectin and its role in innate immunity[J]. Transfus Med,2002,12(6):335. |
[6]
|
ISHII M,OHSAWA I,INOSHITA H,et al. Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients,and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency[J]. Ther Apher Dial,2011,15(5):441. |
[7]
|
TURNER MW. The role of mannose-binding lectin in health and disease[J]. Mol Immunol,2003,40(7):423. |
[8]
|
LEE Y,WITTE T,MOMOT T,et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus:two case-control studies and a meta-analysis[J]. Arthr Rheumat,2005,52(12):3966. |
[9]
|
FORTPIED J,VERTOMMEN D,VAN SCHAFTINGEN E. Binding of mannose-binding lectin to fructosamines:a potential link between hyperglycaemia and complement activation in diabetes[J]. Diabetes Metab Res Rev,2010,26(4):254. |
[10]
|
杨玉玺,黄颂敏,颜晓勇,等.糖尿病肾病模型中NF-κB与甘露聚糖结合凝集素途径补体激活的关系[J].四川大学学报(医学版),2011,4:11. |
[11]
|
HUANG P,ZHANG Y,JIANG T,et al. Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cell[J]. Mol Biol Rep,2010,37(6):3017. |
[12]
|
李晓丽,孙卫华,裴晓艳,等. 2型糖尿病肾病的危险因素分析[J].蚌埠医学院学报,2014,39(12):1621. |
[13]
|
王春霞,刘阁玲,王秋成. 2型糖尿病患者甘露糖结合凝集素及IL-6、IL-8、IL-17、IL-23的变化[J].中国老年学杂志,2013, 33(8):1761. |
[14]
|
HANSEN TK,GALL MA,TARNOW L,et al. Mannose-binding lectin and mortality in type 2 diabetes[J]. Arch Intern Med, 2006,166(18):2007. |
[15]
|
ELAWA G, AOUDALLAH AM, HASANEEN AE, et al. The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients[J]. Saudi Med J,2011,32(8):784. |
[16]
|
MIKAELYAN MV,POGHOSYAN GG,STEPANYAN IE,et al. Effect of lysozyme on plasma membranes of liver and heart cells:lectin binding assay[J]. Cell Biol Int,2007,31(7):699. |
[17]
|
HANSEN TK,THIEL S,WOUTERS PJ,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels[J]. J Clin Endocrinol Metab,2003,88(3):1082. |
[18]
|
ROOS A,DAHA MR,VAN PELT J,et al. Mannose-binding lectin and the kidney[J]. Nephr Dialysis Transplant,2007,22(12):3370. |
[19]
|
常保超,陈卫东,张燕,等.来氟米特对糖尿病大鼠肾组织甘露糖结合凝集素表达的影响[J].第三军医大学学报,2014, 36(13):1402. |
[20]
|
覫STERGAARD JA,BJERRE M,RAMACHANDRARAO SP,et al. Mannan-binding lectin in diabetic kidney disease:the impact of mouse genetics in a type 1 diabetes model[J]. Exp Diabetes Res,2012,2012:678381. |
[21]
|
祁娟,许烨.甘露聚糖结合凝集素基因多态性与妊娠糖尿病的关系[J].临床检验杂志,2014,31(4):256. |
[22]
|
TAKAHASHI K,CHANG WC,TAKAHASHI M,et al. Mannose-binding lectin and its associated proteases(MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection,including disseminated intravascular coagulation[J]. Immunobiology,2011,216(1):96. |
[23]
|
MOJAHEDI MJ,BONAKDARAN S,HAMI M,et al. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus[J]. Iran J Kidney Dis,2009,3(1):12. |
[24]
|
YANG W,LU J,WENG J,et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med,2010,362(12):1090. |
[25]
|
GEHAN H,OLFAT MH,HALA M,et al. Haptoglobin phenotypes as a risk factor for coronary artery disease in type 2 diabetes mellitus:an Egyptain study[J]. Egyptian J Med Hum Genetics, 2014,15(3):257. |
[26]
|
杨庆玲.血清CRP、TNF-α、IL-6和IL-8水平在2型糖尿病肾病患者中的变化及临床意义[J].中国医药指南,2011, 9(31):252. |
[27]
|
ANAND SS, YUSUF S. C-reactive protein is a bystander of cardiovascular disease[J]. Eur Heart J,2010,31(17):2092. |
[28]
|
HANSEN TK,FORSBLOM C,SARAHEIMO M,et al. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes[J]. Diabetologia,2010,53(7):1517. |